title: Development of anti-factor XIII antibodies in a patient with hereditary factor XIII deficiency receiving therapy for chronic hepatitis C.
authors.affiliation: Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.
authors.forename: R
authors.initials: R
authors.lastname: Sosa
authors.forename: D
authors.initials: D
authors.lastname: Gailani
authors.forename: A T
authors.initials: AT
authors.lastname: Neff
mesh_terms: D000328:Adult; D000906:Antibodies / Q000276:immunology*; D000998:Antiviral Agents / Q000627:therapeutic use; D019774:Blood Coagulation Factor Inhibitors / Q000276:immunology; D005176:Factor XIII / Q000276:immunology* / Q000627:therapeutic use; D005177:Factor XIII Deficiency / Q000150:complications* / Q000188:drug therapy / Q000276:immunology*; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000906:Antibodies; D000998:Antiviral Agents; D019774:Blood Coagulation Factor Inhibitors; D007166:Immunosuppressive Agents; D005176:Factor XIII